How Pathways AI collects, uses, stores and protects personal and health information across Australia, the United Kingdom and the United States — and the rights you have over it.
Pathways AI Pty Ltd (ACN [INSERT]) (“Pathways”, “we”, “us”, “our”) provides clinical reasoning support software, including the Differential, Socrates and Scribe products (the “Services”), at getpathways.ai and app.getpathways.ai.
This Privacy Policy explains how we collect, use, disclose, store and protect personal information and health information when you visit our websites, interact with us, or use the Services. It is written to comply with the Australian Privacy Act 1988 (Cth) and the Australian Privacy Principles, the UK GDPR and the Data Protection Act 2018, and applicable United States federal and state privacy laws, including HIPAA, the CCPA/CPRA and comparable state statutes.
Pathways AI Pty Ltd is an Australian proprietary limited company that develops clinical decision support software for licensed healthcare professionals.
Pathways is a clinical decision support tool designed to assist — never replace — the clinical judgement of qualified healthcare professionals. The clinician is always the final decision-maker.
| Entity | Pathways AI Pty Ltd (ACN 695 207 606) |
| Registered office | L6, 20 Bungan Street, Mona Vale NSW 2103, Australia |
| Privacy Officer (AU) | privacy@getpathways.ai |
| Data Protection Officer (UK / EEA) | dpo@getpathways.ai |
| HIPAA Privacy Officer (US) | hipaa@getpathways.ai |
| Postal address | As above |
This policy applies to:
Patients: Where a healthcare provider uses the Services to support care for a patient, the healthcare provider is the entity that decides how and why the patient’s information is handled. In Australian terms they are the relevant APP entity; in UK / EU terms they are the data controller; in US terms they are the HIPAA covered entity. Pathways acts on their behalf as a service provider, processor and (where HIPAA applies) business associate. Patients with questions about their information should contact their healthcare provider in the first instance.
| Term | Meaning |
|---|---|
| Personal information / personal data | Information that identifies, or could reasonably identify, an individual. Includes “personal information” under the Australian Privacy Act, “personal data” under the UK GDPR, and “personal information” under the CCPA/CPRA. |
| Health information / PHI | Information about an individual’s health, disability, or the health services provided to them. In the United States, this includes Protected Health Information (PHI) as defined under HIPAA when handled on behalf of a covered entity. |
| Sensitive information / special category data | A subset of personal information given heightened protection under each regime, including health information, genetic and biometric data, and information about race, sexual orientation and religious beliefs. |
| De-identified data | Information from which identifiers have been removed so that an individual cannot reasonably be identified, in accordance with OAIC guidance, the HIPAA Safe Harbor or Expert Determination method, and UK ICO anonymisation guidance. |
| Customer | A healthcare provider, practice, hospital, clinic or other organisation that subscribes to the Services. |
| Authorised user | An individual (typically a clinician or practice staff member) authorised by a Customer to access the Services. |
The categories of information we collect depend on how you interact with us.
When Customers and Authorised Users use the Services, we process clinical content on their behalf. This may include:
PHI is stripped before model inference. Direct identifiers are removed from clinical content before it is sent to any large language model used by the reasoning pipeline. Re-identification keys are held separately in our Australian environment and are not exposed to model providers.
We use the information described above for the following purposes:
| Purpose | Lawful basis (UK GDPR) / authorisation |
|---|---|
| Providing and operating the Services for our Customers, including running the clinical reasoning pipeline, verification, contextualisation, diagnosis, planning and output phases. | Performance of a contract with the Customer; legitimate interests in operating our business; Customer consent and instructions (where applicable, on behalf of patients). |
| Authenticating users, managing access, generating audit logs, and securing the Services. | Legitimate interests in security and integrity; legal obligations relating to records and security; APP 11. |
| Supporting Customers, responding to enquiries, providing training and managing accounts. | Performance of a contract; legitimate interests. |
| Improving the Services, including diagnostics, error analysis, and model and pipeline performance evaluation using de-identified data only. | Legitimate interests, subject to de-identification; consent where required. |
| Marketing our products to existing and prospective Customers by email or phone. | Consent (where required); legitimate interests in promoting our services to professional contacts. You can opt out at any time. |
| Complying with legal obligations, including notifiable data breach reporting, tax, accounting, regulatory enquiries and responding to lawful requests. | Legal obligation; legitimate interests. |
| Establishing, exercising or defending legal claims. | Legitimate interests; legal obligation. |
No secondary use of identifiable clinical content. We do not use identifiable clinical content (including PHI) to train third-party large language models, to develop new commercial products, or for any purpose other than providing the Services to the Customer that submitted it — unless we have an explicit lawful basis to do so (such as the patient’s express consent, an authorisation from the Customer that itself has consent, or where the data has been de-identified to the relevant standard).
For Customers in Australia, PHI and other clinical content are processed and stored in AWS Sydney (ap-southeast-2). PHI does not leave Australia, except where strictly necessary to deliver the Services and only under the safeguards described below. This commitment is contractual and enforced at the infrastructure level.
For UK Customers, primary processing of clinical content occurs in AWS London eu-west-2. Where data is transferred outside the UK, we rely on:
For US Customers, processing occurs in AWS US East-1. Where Pathways is acting as a HIPAA business associate, a Business Associate Agreement (BAA) governs the processing and the Services are operated in a HIPAA-aligned environment.
Where personal information collected from Australia, the UK or the US is transferred to another jurisdiction (for example, to support staff or sub-processors), we take reasonable steps to ensure the recipient handles the information consistently with this policy and the law of the originating jurisdiction. Under Australian Privacy Principle 8, Pathways remains accountable for the acts of its overseas recipients.
We maintain a layered security program designed for clinical data:
No security measure is perfect. While we apply industry-leading controls appropriate to clinical data, we cannot guarantee absolute security. Authorised Users are responsible for safeguarding their credentials and notifying us of any suspected unauthorised access.
We retain information for the period necessary to provide the Services and to meet our legal, accounting and regulatory obligations. Retention periods include:
When information is no longer needed and there is no legal basis to retain it, we securely destroy, delete or de-identify it.
Your rights depend on where you live and which law applies. Pathways supports the following rights:
Automated decision-making. Pathways produces clinical decision support — ranked differentials, evidence chains, self-critique and safety screening — that is reviewed and acted on by a qualified clinician. The clinician is always the final decision-maker. Pathways does not make solely automated decisions with legal or similarly significant effects on patients within the meaning of Article 22 UK GDPR.
Where Pathways processes PHI on behalf of a HIPAA covered entity, the individual rights set out in 45 CFR Part 164 — including the right to access, amend and receive an accounting of disclosures of PHI — are exercised through the covered entity. Pathways will support the covered entity in responding to such requests in accordance with the BAA.
California residents have the right to:
We do not sell personal information within the meaning of the CCPA/CPRA, and we do not share personal information for cross-context behavioural advertising. PHI handled subject to HIPAA is exempt from the CCPA/CPRA.
Residents of states with comprehensive privacy laws — including Virginia, Colorado, Connecticut, Utah, Texas, Oregon, Montana and others as those laws come into force — have rights to access, correct, delete and port their personal information, to opt out of targeted advertising and profiling for decisions with legal or similarly significant effects, and to appeal our decisions on rights requests. PHI processed under HIPAA is exempt from these state laws.
Email privacy@getpathways.ai with “Privacy rights request” in the subject line, or write to us at the postal address above. We will respond within the time limits set by applicable law (generally one month under UK GDPR, 45 days under CCPA/CPRA, and a reasonable time under the Privacy Act). We may need to verify your identity before acting on a request. There is generally no fee, although fees may apply in limited circumstances for excessive or repetitive requests.
Authorised agents. Under the CCPA/CPRA and similar laws, you may use an authorised agent. We will require written proof of the agent’s authority and may verify the request directly with you.
The Services are made available only to healthcare professionals and other adult Authorised Users. We do not knowingly collect personal information directly from children. The Services may, however, process the health information of paediatric patients on behalf of healthcare provider Customers; in those circumstances the Customer is responsible for any parental or guardian consent required by law.
We do not knowingly sell or share personal information of consumers under the age of 16 within the meaning of the CCPA/CPRA, and we comply with COPPA in relation to children under 13 in the United States.
We maintain an incident response process designed to detect, contain, investigate and remediate security incidents quickly.
Pathways is positioned as clinical decision support. It does not diagnose, treat, cure or prevent any disease. The clinician is always the final decision-maker. Differentials, confidence scores, evidence chains, self-critique and safety screening outputs produced by the Services are intended to support, not replace, the independent professional judgement of a qualified healthcare professional. The regulatory status of the Services varies by jurisdiction and is set out in our Clinical Disclaimer.
We may update this policy from time to time. The “Last updated” date at the top reflects the most recent revision. If we make material changes, we will notify you by email (to the address associated with your account or your Customer’s account) or by prominent notice in the Services before the change takes effect, and where required by law we will seek your fresh consent.
If you have a privacy concern, please contact us first so we can try to resolve it. We aim to acknowledge complaints within 5 business days and resolve them within 30 days. If you are not satisfied with our response you may complain to the relevant regulator:
| Jurisdiction | Regulator |
|---|---|
| Australia | Office of the Australian Information Commissioner (OAIC) — oaic.gov.au — 1300 363 992 |
| United Kingdom | Information Commissioner’s Office (ICO) — ico.org.uk — 0303 123 1113 |
| United States — HIPAA | U.S. Department of Health and Human Services, Office for Civil Rights — hhs.gov/ocr |
| California | California Privacy Protection Agency (CPPA) — cppa.ca.gov; or California Attorney General — oag.ca.gov/privacy |
| Other US states | The Attorney General or designated privacy regulator in your state. |
This document is a template that has been tailored to Pathways AI’s product description. Before publication, it should be reviewed by qualified legal counsel in each of Australia, the United Kingdom and the United States, and the bracketed placeholders should be completed with current operational details (entity numbers, regions, sub-processor list, retention periods and representative information).